Person A/Pr Sherene Loi National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in Benefit of 2D-strain surveillance in improving cardiovascular outcomes in cancer patients undergoing cardiotoxic chemotherapy (funded by National Health and Medical Research Council) Participant in CAPTURE: Circulating tumour DNA assessment of PIK3CA to guide treatment response (funded by National Health and Medical Research Council) Principal investigator of Combining PI3K, CDK4/6 pathway inhibitors and immunotherapies in triple-negative breast cancer (TNBC): a novel therapy combination (funded by National Health and Medical Research Council) Principal investigator of Molecular profiling residual disease from early stage HER2 positive breast cancer treated with neoadjuvant chemo- and anti-HER2 therapy (funded by National Health and Medical Research Council) Participant in Randomised phase III trial of adjuvant radiotherapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised low-risk luminal A early breast cancer (funded by National Health and Medical Research Council) View all 8 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in Benefit of 2D-strain surveillance in improving cardiovascular outcomes in cancer patients undergoing cardiotoxic chemotherapy (funded by National Health and Medical Research Council) Participant in CAPTURE: Circulating tumour DNA assessment of PIK3CA to guide treatment response (funded by National Health and Medical Research Council) Principal investigator of Combining PI3K, CDK4/6 pathway inhibitors and immunotherapies in triple-negative breast cancer (TNBC): a novel therapy combination (funded by National Health and Medical Research Council) Principal investigator of Molecular profiling residual disease from early stage HER2 positive breast cancer treated with neoadjuvant chemo- and anti-HER2 therapy (funded by National Health and Medical Research Council) Participant in Randomised phase III trial of adjuvant radiotherapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised low-risk luminal A early breast cancer (funded by National Health and Medical Research Council) View all 8 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
